𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormone escape is associated with genomic instability in a human prostate cancer model

✍ Scribed by Marie-Emmanuelle Legrier; Charlotte Guyader; Jocelyn Céraline; Bernard Dutrillaux; Stéphane Oudard; Marie-France Poupon; Nathalie Auger


Book ID
102862702
Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
505 KB
Volume
124
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Lack of hormone dependency in prostate cancers is an irreversible event that occurs through generation of genomic instability induced by androgen deprivation. Indeed, the cytogenetic profile of hormone‐dependent (HD) prostate cancer remains stable as long as it received a hormone supply, whereas the profile of hormone‐independent (HID) variants acquired new and various alterations. This is demonstrated here using a HD xenografted model of a human prostate cancer, PAC120, transplanted for 11 years into male nude mice and 4 HID variants obtained by surgical castration. Cytogenetic analysis, done by karyotype, FISH, CGH and array‐CGH, shows that PAC120 at early passage presents numerous chromosomal alterations. Very few additional alterations were found between the 5th and 47th passages, indicating the stability of the parental tumor. HID variants largely maintained the core of chromosomal alterations of PAC120 — losses at 6q, 7p, 12q, 15q and 17q sites. However, each HID variant displayed a number of new alterations, almost all being specific to each variant and very few shared by all. None of the HID had androgen receptor mutations. Our study indicates that hormone castration is responsible for genomic instability generating new cytogenetic abnormalities susceptible to alter the properties of cancer cell associated with tumor progression, such as increased cell survival and ability to metastasize. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Amplification of the androgen receptor g
✍ Koivisto, Pasi A.; Rantala, Immo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

p53 protein expression of 30 hormone-refractory locally recurrent prostate cancers was compared with their matched untreated primary tumour specimens. In addition, androgen receptor (AR) gene amplification and p53 protein immunostaining were compared. p53 positivity increased during hormonal therapy